These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20372826)

  • 1. Integrative genomic analyses on IL28RA, the common receptor of interferon-lambda1, -lambda2 and -lambda3.
    Yang L; Luo Y; Wei J; He S
    Int J Mol Med; 2010 May; 25(5):807-12. PubMed ID: 20372826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative genomic analyses on interferon-lambdas and their roles in cancer prediction.
    Yang L; Wei J; He S
    Int J Mol Med; 2010 Feb; 25(2):299-304. PubMed ID: 20043142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex.
    Kotenko SV; Gallagher G; Baurin VV; Lewis-Antes A; Shen M; Shah NK; Langer JA; Sheikh F; Dickensheets H; Donnelly RP
    Nat Immunol; 2003 Jan; 4(1):69-77. PubMed ID: 12483210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses.
    Li M; Liu X; Zhou Y; Su SB
    J Leukoc Biol; 2009 Jul; 86(1):23-32. PubMed ID: 19304895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-27, a cytokine, and IFN-λ1, a type III IFN, are coordinated to regulate virus replication through type I IFN.
    Cao Y; Zhang R; Zhang W; Zhu C; Yu Y; Song Y; Wang Q; Bai L; Liu Y; Wu K; Wu J
    J Immunol; 2014 Jan; 192(2):691-703. PubMed ID: 24337382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.
    Bartlett NW; Buttigieg K; Kotenko SV; Smith GL
    J Gen Virol; 2005 Jun; 86(Pt 6):1589-1596. PubMed ID: 15914836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes.
    Osterlund PI; Pietilä TE; Veckman V; Kotenko SV; Julkunen I
    J Immunol; 2007 Sep; 179(6):3434-42. PubMed ID: 17785777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of transposable elements in the regulation of IFN-lambda1 gene expression.
    Thomson SJ; Goh FG; Banks H; Krausgruber T; Kotenko SV; Foxwell BM; Udalova IA
    Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11564-9. PubMed ID: 19570999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential anti-tumor effect of IFN-λ2 (IL-28A) against human lung cancer cells.
    Tezuka Y; Endo S; Matsui A; Sato A; Saito K; Semba K; Takahashi M; Murakami T
    Lung Cancer; 2012 Dec; 78(3):185-92. PubMed ID: 23021208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of interleukins-28 and -29: comparison with type I interferons.
    Meager A; Visvalingam K; Dilger P; Bryan D; Wadhwa M
    Cytokine; 2005 Jul; 31(2):109-18. PubMed ID: 15899585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression.
    Bolen CR; Ding S; Robek MD; Kleinstein SH
    Hepatology; 2014 Apr; 59(4):1262-72. PubMed ID: 23929627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral infections activate types I and III interferon genes through a common mechanism.
    Onoguchi K; Yoneyama M; Takemura A; Akira S; Taniguchi T; Namiki H; Fujita T
    J Biol Chem; 2007 Mar; 282(10):7576-81. PubMed ID: 17204473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma.
    Lasfar A; Lewis-Antes A; Smirnov SV; Anantha S; Abushahba W; Tian B; Reuhl K; Dickensheets H; Sheikh F; Donnelly RP; Raveche E; Kotenko SV
    Cancer Res; 2006 Apr; 66(8):4468-77. PubMed ID: 16618774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of interferon-λ in minor salivary glands of patients with primary Sjögren's syndrome and its synergic effect with interferon-α on salivary gland epithelial cells.
    Ha YJ; Choi YS; Kang EH; Chung JH; Cha S; Song YW; Lee YJ
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):31-40. PubMed ID: 28421993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL28RA inhibits human epidermal keratinocyte proliferation by inhibiting cell cycle progression.
    Yin X; Zhang S; Li B; Zhang Y; Zhang X
    Mol Biol Rep; 2019 Feb; 46(1):1189-1197. PubMed ID: 30632069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antiviral activity of lambda-interferons against HIV replication in macrophages.
    Wang Y; Li J; Wang X; Zhou Y; Zhang T; Ho W
    J Interferon Cytokine Res; 2015 Mar; 35(3):213-21. PubMed ID: 25268605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
    Chiriac MT; Buchen B; Wandersee A; Hundorfean G; Günther C; Bourjau Y; Doyle SE; Frey B; Ekici AB; Büttner C; Weigmann B; Atreya R; Wirtz S; Becker C; Siebler J; Neurath MF
    Gastroenterology; 2017 Jul; 153(1):123-138.e8. PubMed ID: 28342759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-28, IL-29 and their class II cytokine receptor IL-28R.
    Sheppard P; Kindsvogel W; Xu W; Henderson K; Schlutsmeyer S; Whitmore TE; Kuestner R; Garrigues U; Birks C; Roraback J; Ostrander C; Dong D; Shin J; Presnell S; Fox B; Haldeman B; Cooper E; Taft D; Gilbert T; Grant FJ; Tackett M; Krivan W; McKnight G; Clegg C; Foster D; Klucher KM
    Nat Immunol; 2003 Jan; 4(1):63-8. PubMed ID: 12469119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysis.
    Li ML; Xu WW; Gao YD; Guo Y; Wang WJ; Wang C; Jiang SY; Willden A; Huang JF; Zhang HT
    PLoS One; 2013; 8(3):e60048. PubMed ID: 23555878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome.
    Apostolou E; Kapsogeorgou EK; Konsta OD; Giotakis I; Saridaki MI; Andreakos E; Tzioufas AG
    Clin Exp Immunol; 2016 Dec; 186(3):304-312. PubMed ID: 27613139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.